日本の薬剤給付管理市場レポート：サービス、ビジネスモデル、最終用途、地域別、2025年～2033年

日本の薬剤給付管理市場規模は2024年に356億5,900万米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに557億3,800万米ドルに達し、2025年から2033年にかけて5.1%の成長率（CAGR）を示すと予測しています。市場を牽引しているのは、処方薬の費用対効果に優れた管理に対する需要の高まりと、機械学習（ML）および人工知能（AI）技術の導入です。

本レポートで回答した主な質問

• 日本の薬剤給付管理市場はこれまでどのように推移し、今後どのように推移するのか？
• COVID-19が日本の薬剤給付管理市場に与えた影響は？
• 日本の薬剤給付管理市場のサービス別区分は？
• 日本の薬剤給付管理市場のビジネスモデル別区分は？
• 日本の薬剤給付管理市場の最終用途別の区分は？
• 日本の薬剤給付管理市場のバリューチェーンにおける各ステージとは？
• 日本の薬剤給付管理の主要な促進要因と課題は何か？
• 日本の薬剤給付管理市場の構造と主要プレーヤーは？
• 日本の薬剤給付管理市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
• 市場推定
• 調査手法

第3章 エグゼクティブサマリー

第4章 薬剤給付管理市場- イントロダクション

• 概要
• 市場力学
• 業界動向
• 競合情報

第5章 日本の薬剤給付管理市場情勢

• 過去および現在の市場動向（2019～2024年）
• 市場予測（2025～2033年）

第6章 日本の薬剤給付管理市場- サービス別の内訳

• 専門薬局サービス
• 医薬品処方管理
• 小売薬局サービス
• 福利厚生プランの設計とコンサルティング
• 疾病管理サービス
• その他

第7章 日本の薬剤給付管理市場- ビジネスモデル別の内訳

• 健康保険管理
• スタンドアロンPBM
• 小売薬局

第8章 日本の薬剤給付管理市場- 最終用途別の内訳

• 連邦政府
• 商業

第9章 日本の薬剤給付管理市場- 競合情勢

• 概要
• 市場構造
• 市場企業のポジショニング
• 主要成功戦略
• 競合ダッシュボード
• 企業評価象限

第10章 主要企業のプロファイル

第11章 日本の薬剤給付管理市場- 業界分析

• 促進要因・抑制要因・機会
• ポーターのファイブフォース分析
• バリューチェーン分析

第12章 付録

Japan pharmacy benefit management market size reached USD 35,659 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 55,738 Million by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The market is being driven by the increasing demand for cost-effective management of prescription medications and the incorporation of machine learning (ML) and artificial intelligence (AI) technologies.

Pharmacy benefit management (PBM) refers to the third-party entities that administer prescription drug programs on behalf of health insurance plans, employers, and other organizations. It plays a crucial role in managing and optimizing the pharmaceutical benefits provided to plan members or employees. Pharmacy benefit management acts as intermediaries between pharmacies, drug manufacturers, and healthcare payers, facilitating the effective and efficient delivery of prescription medications. It performs various functions, including negotiating drug prices with pharmaceutical companies, developing, and maintaining formularies, processing prescription claims, and managing pharmacy networks. Pharmacy benefit management aims to control prescription drug costs, promote generic drug utilization, ensure medication safety, and improve overall health outcomes.

Japan Pharmacy Benefit Management Market Trends:

In the Japan market, the driving force behind its growth lies in the imperative need for effective management of prescription drug costs. Additionally, the increasing pricing of medications has intensified the demand for pharmacy benefit management (PBM) services among health insurance providers, creating attractive opportunities for market expansion. Furthermore, the presence of similar drugs with slight variations in their active pharmaceutical ingredients (API) has heightened price sensitivity among consumers, resulting in a heightened demand for PBM services. Furthermore, the incorporation of machine learning (ML) and artificial intelligence (AI) technologies has played a pivotal role in enhancing operational efficiency. These technologies have streamlined supply chain processes, facilitated swifter order delivery, and catered to multiple insurance and retail pharmacy chains within limited timeframes. Additionally, there is a noticeable shift towards pharmacy benefit management systems due to their capacity to provide enhanced expertise and establish connections with leading companies. Furthermore, ongoing enhancements and the increasing availability of healthcare data are instigating significant transformations within the regional market. Apart from this, PBMs are harnessing the potential of data analytics, artificial intelligence, and machine learning to offer more personalized, data-driven pharmacy benefit solutions, which is expected to fuel the market growth in the coming years.

Japan Pharmacy Benefit Management Market Segmentation:

Service Insights:

• Specialty Pharmacy Services
• Drug Formulary Management
• Retail Pharmacy Services
• Benefit Plan Design and Consultation
• Disease Management Services
• Others

Business Model Insights:

• Health Insurance Management
• Standalone PBMs
• Retail Pharmacy

End Use Insights:

• Federal
• Commercial

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan pharmacy benefit management market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan pharmacy benefit management market?
• What is the breakup of the Japan pharmacy benefit management market on the basis of service?
• What is the breakup of the Japan pharmacy benefit management market on the basis of business model?
• What is the breakup of the Japan pharmacy benefit management market on the basis of end use?
• What are the various stages in the value chain of the Japan pharmacy benefit management market?
• What are the key driving factors and challenges in the Japan pharmacy benefit management?
• What is the structure of the Japan pharmacy benefit management market and who are the key players?
• What is the degree of competition in the Japan pharmacy benefit management market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Pharmacy Benefit Management Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Pharmacy Benefit Management Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Pharmacy Benefit Management Market - Breakup by Service

• 6.1 Specialty Pharmacy Services
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Drug Formulary Management
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Retail Pharmacy Services
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)
• 6.4 Benefit Plan Design and Consultation
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2019-2024)
  • 6.4.3 Market Forecast (2025-2033)
• 6.5 Disease Management Services
  • 6.5.1 Overview
  • 6.5.2 Historical and Current Market Trends (2019-2024)
  • 6.5.3 Market Forecast (2025-2033)
• 6.6 Others
  • 6.6.1 Historical and Current Market Trends (2019-2024)
  • 6.6.2 Market Forecast (2025-2033)

7 Japan Pharmacy Benefit Management Market - Breakup by Business Model

• 7.1 Health Insurance Management
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Standalone PBMs
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Retail Pharmacy
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)

8 Japan Pharmacy Benefit Management Market - Breakup by End Use

• 8.1 Federal
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Commercial
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)

9 Japan Pharmacy Benefit Management Market - Competitive Landscape

• 9.1 Overview
• 9.2 Market Structure
• 9.3 Market Player Positioning
• 9.4 Top Winning Strategies
• 9.5 Competitive Dashboard
• 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

• 10.1 Company A
  • 10.1.1 Business Overview
  • 10.1.2 Services Offered
  • 10.1.3 Business Strategies
  • 10.1.4 SWOT Analysis
  • 10.1.5 Major News and Events
• 10.2 Company B
  • 10.2.1 Business Overview
  • 10.2.2 Services Offered
  • 10.2.3 Business Strategies
  • 10.2.4 SWOT Analysis
  • 10.2.5 Major News and Events
• 10.3 Company C
  • 10.3.1 Business Overview
  • 10.3.2 Services Offered
  • 10.3.3 Business Strategies
  • 10.3.4 SWOT Analysis
  • 10.3.5 Major News and Events
• 10.4 Company D
  • 10.4.1 Business Overview
  • 10.4.2 Services Offered
  • 10.4.3 Business Strategies
  • 10.4.4 SWOT Analysis
  • 10.4.5 Major News and Events
• 10.5 Company E
  • 10.5.1 Business Overview
  • 10.5.2 Services Offered
  • 10.5.3 Business Strategies
  • 10.5.4 SWOT Analysis
  • 10.5.5 Major News and Events

11 Japan Pharmacy Benefit Management Market - Industry Analysis

• 11.1 Drivers, Restraints, and Opportunities
  • 11.1.1 Overview
  • 11.1.2 Drivers
  • 11.1.3 Restraints
  • 11.1.4 Opportunities
• 11.2 Porters Five Forces Analysis
  • 11.2.1 Overview
  • 11.2.2 Bargaining Power of Buyers
  • 11.2.3 Bargaining Power of Suppliers
  • 11.2.4 Degree of Competition
  • 11.2.5 Threat of New Entrants
  • 11.2.6 Threat of Substitutes
• 11.3 Value Chain Analysis

12 Appendix